Concepedia

Oral glutamine increases circulating glucagon-like peptide 1, glucagon, and insulin concentrations in lean, obese, and type 2 diabetic subjects

Jerry R. Greenfield, I. Sadaf Farooqi, Julia M. Keogh, Elana Henning, Abdella M. Habib, Anthea Blackwood, Frank Reimann, Jens J. Holst, Fiona M. Gribble

American Journal of Clinical Nutrition · 2008 · 253 citations · 19 references

DOI

Concepts

References

19

Gut hormone PYY3-36 physiologically inhibits food intake

Rachel L. Batterham, Michael A. Cowley, Caroline J. Small et al. · Nature · 2002 · 2.3K citations

, , +14

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.

Michael A. Nauck, Markus M. Heimesaat, Jens J. Holst et al. · Journal of Clinical Investigation · 1993 · 1.6K citations · Full text

, , +15

Inhibition of Food Intake in Obese Subjects by Peptide YY<sub>3–36</sub>

Rachel L. Batterham, Mark A. Cohen, Carel W. le Roux et al. · New England Journal of Medicine · 2003 · 1.6K citations

, , +16

Tissue and Plasma Concentrations of Amidated and Glycine-Extended Glucagon-Like Peptide I in Humans

Cathrine Ørskov, L. Rabenhøj, André Wettergren et al. · Diabetes · 1994 · 892 citations

, , +5

Reduced Postprandial Concentrations of Intact Biologically Active Glucagon-Like Peptide 1 in Type 2 Diabetic Patients

Tina Vilsbøll, Thure Krarup, Carolyn F. Deacon et al. · Diabetes · 2001 · 884 citations · Full text

, , +16